跳至主要内容
临床试验/CTRI/2024/08/071841
CTRI/2024/08/071841尚未招募2/3 期

Comparison between oral levetiracetam vs oral sodium valproate as a first line therapy in children with newly diagnosed epilepsy - a randomised controlled trial

Pandit bhagwat Dayal Sharma postgraduate institute of medical sciences rohtak1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To compare the frequency of repeat seizure at 3 months post treatment in valproate and levetiracetam group

研究概览

简要总结

As there is very less data available for the treatment of childhood epilepsy . It is therefore a small effort from my side in contributing about the treatment of childhood epilepsy.In my study there will be  comparison of 2 antiepileptic drugs  -levetiracetam and sodium valproate  role in managing childhood epilepsy in age group between 2-14 years and see the frequency of repeat seizure and adverse effect of both these drugs.

Hence with this study we will be able to see which drug is better in managing childhood epilepsy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
2.00 Year(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • 1.Children aged 2-14 years with New diagnosed epilepsy.

排除标准

  • 1.Age less than 2 and more than 14 years 2.Simple febrile seizure 3.Seizure secondary to other condition.

结局指标

主要结局

To compare the frequency of repeat seizure at 3 months post treatment in valproate and levetiracetam group

时间窗: 12 weeks

次要结局

  • To see the adverse effects of both these drugs -levetiracetam & sodium valproate(12 weeks)

研究者

发起方
Pandit bhagwat Dayal Sharma postgraduate institute of medical sciences rohtak
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Deepak Pahal

Pandit bhagwat Dayal Sharma postgraduate institute of medical sciences Rohtak

研究点 (1)

Loading locations...

相似试验